What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q3 2019?

117 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q3 2019. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 61,617,508
Share change: +59,183
Total reported value: $327,170,529
Put/Call ratio: 350%
Price per share: $5.31
Number of holders: 117
Value change: +$8,126,558
Number of buys: 69
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2019
Previous quarter: Q2 2019

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Consonance Capital Management LP	13F	Company	15%	17,875,655	$68,643,000	—	30 Jun 2019	13F
BlackRock Finance, Inc.	13F	Company	6.6%	8,078,995	$31,023,000	—	30 Jun 2019	13F
ARMISTICE CAPITAL, LLC	13F	Company	4.1%	5,000,000	$19,200,000	—	30 Jun 2019	13F
VANGUARD GROUP INC	13F	Company	3.9%	4,861,728	$18,669,000	—	30 Jun 2019	13F
MANGROVE PARTNERS IM, LLC	13F	Company	3.1%	3,837,181	$14,735,000	—	30 Jun 2019	13F
Broadfin Capital, LLC	13F	Company	2.2%	2,765,070	$10,618,000	—	30 Jun 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	2.1%	2,559,461	$9,828,000	—	30 Jun 2019	13F
MORGAN STANLEY	13F	Company	2%	2,522,301	$9,686,000	—	30 Jun 2019	13F
STATE STREET CORP	13F	Company	1.5%	1,821,191	$6,993,000	—	30 Jun 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,403,791	$5,390,000	—	30 Jun 2019	13F
NORTHERN TRUST CORP	13F	Company	0.94%	1,157,742	$4,444,000	—	30 Jun 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.78%	956,946	$3,569,000	—	30 Jun 2019	13F
Atom Investors LP	13F	Company	0.59%	728,999	$2,799,000	—	30 Jun 2019	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.39%	486,064	$1,869,000	—	30 Jun 2019	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.35%	432,929	$1,662,000	—	30 Jun 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.33%	404,030	$1,551,000	—	30 Jun 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	394,565	$1,515,000	—	30 Jun 2019	13F
Bank of New York Mellon Corp	13F	Company	0.29%	352,902	$1,355,000	—	30 Jun 2019	13F
Brandywine Global Investment Management, LLC	13F	Company	0.28%	349,072	$1,341,000	—	30 Jun 2019	13F
David M. Knott	13F	Individual	0.28%	343,347	$1,318,000	—	30 Jun 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.24%	297,238	$1,141,000	—	30 Jun 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.23%	280,438	$1,077,000	—	30 Jun 2019	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.19%	237,536	$912,000	—	30 Jun 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	226,188	$869,000	—	30 Jun 2019	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.18%	225,584	$866,000	—	30 Jun 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.17%	211,545	$812,000	—	30 Jun 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.14%	175,953	$676,000	—	30 Jun 2019	13F
Swiss National Bank	13F	Company	0.14%	172,100	$661,000	—	30 Jun 2019	13F
STRS OHIO	13F	Company	0.14%	168,500	$647,000	—	30 Jun 2019	13F
CHICAGO EQUITY PARTNERS LLC	13F	Company	0.13%	163,400	$627,000	—	30 Jun 2019	13F
ClariVest Asset Management LLC	13F	Company	0.13%	158,700	$610,000	—	30 Jun 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	149,876	$576,000	—	30 Jun 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.12%	148,800	$571,000	—	30 Jun 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.12%	148,765	$571,000	—	30 Jun 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.11%	131,200	$504,000	—	30 Jun 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	126,182	$485,000	—	30 Jun 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.1%	117,692	$452,000	—	30 Jun 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	104,178	$400,000	—	30 Jun 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.08%	96,894	$372,000	—	30 Jun 2019	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.08%	94,960	$365,000	—	30 Jun 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.07%	90,364	$347,000	—	30 Jun 2019	13F
Lido Advisors, LLC	13F	Company	0.07%	86,304	$331,000	—	30 Jun 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	86,085	$330,000	—	30 Jun 2019	13F
Cubist Systematic Strategies, LLC	13F	Company	0.07%	81,806	$314,000	—	30 Jun 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	76,373	$293,272	—	30 Jun 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.06%	76,416	$293,000	—	30 Jun 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.05%	65,895	$253,000	—	30 Jun 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.05%	63,211	$243,000	—	30 Jun 2019	13F
BARCLAYS PLC	13F	Company	0.05%	62,193	$239,000	—	30 Jun 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	61,556	$236,000	—	30 Jun 2019	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2019

As of 30 Sep 2019, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,617,508 shares. The largest 10 holders included Consonance Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, MANGROVE PARTNERS, GEODE CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, NORTHERN TRUST CORP, and EMERALD ADVISERS, LLC. This page lists 117 institutional shareholders reporting positions in this security for the Q3 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders

Q3 2019 holders

117

Holder diff

Investor	Q2 2019 Shares	Q3 2019 Shares	Share Diff	Share Chg %	Q2 2019 Value $	Q3 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.